These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28197915)

  • 1. The Role of Sumoylation in Senescence.
    Scurr LL; Haferkamp S; Rizos H
    Adv Exp Med Biol; 2017; 963():215-226. PubMed ID: 28197915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci.
    Ye X; Zerlanko B; Zhang R; Somaiah N; Lipinski M; Salomoni P; Adams PD
    Mol Cell Biol; 2007 Apr; 27(7):2452-65. PubMed ID: 17242198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
    He X; Riceberg J; Pulukuri SM; Grossman S; Shinde V; Shah P; Brownell JE; Dick L; Newcomb J; Bence N
    PLoS One; 2015; 10(4):e0123882. PubMed ID: 25860128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
    Li T; Santockyte R; Shen RF; Tekle E; Wang G; Yang DC; Chock PB
    J Biol Chem; 2006 Nov; 281(47):36221-7. PubMed ID: 17012228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
    McManus FP; Bourdeau V; Acevedo M; Lopes-Paciencia S; Mignacca L; Lamoliatte F; Rojas Pino JW; Ferbeyre G; Thibault P
    Sci Rep; 2018 May; 8(1):7754. PubMed ID: 29773808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumo Modification of Ion Channels.
    Benson M; Iñiguez-Lluhí JA; Martens J
    Adv Exp Med Biol; 2017; 963():127-141. PubMed ID: 28197910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
    Shih HM; Chang CC; Kuo HY; Lin DY
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
    Sahin U; de Thé H; Lallemand-Breitenbach V
    Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wrestling with Chromosomes: The Roles of SUMO During Meiosis.
    Nottke AC; Kim HM; Colaiácovo MP
    Adv Exp Med Biol; 2017; 963():185-196. PubMed ID: 28197913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMOylation of p53 mediates interferon activities.
    Marcos-Villar L; Pérez-Girón JV; Vilas JM; Soto A; de la Cruz-Hererra CF; Lang V; Collado M; Vidal A; Rodríguez MS; Muñoz-Fontela C; Rivas C
    Cell Cycle; 2013 Sep; 12(17):2809-16. PubMed ID: 23966171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO and Nucleocytoplasmic Transport.
    Ptak C; Wozniak RW
    Adv Exp Med Biol; 2017; 963():111-126. PubMed ID: 28197909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Cellular Processes by SUMO: Understudied Topics.
    Enserink JM
    Adv Exp Med Biol; 2017; 963():89-97. PubMed ID: 28197907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
    Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
    Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants.
    Fang W; Mori T; Cobrinik D
    Oncogene; 2002 Aug; 21(36):5557-65. PubMed ID: 12165854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of nuclear activities by substrate-selective and protein-group SUMOylation.
    Jentsch S; Psakhye I
    Annu Rev Genet; 2013; 47():167-86. PubMed ID: 24016193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.